First-of-Its-Kind Clinical Study Initiated to Investigate Potential Benefits of Nicotinamide Riboside Combined With Exercise in Older Adults With Hypertension
ChromaDex Corp., the global scientific authority on nicotinamide adenine dinucleotide (NAD) and nicotinamide riboside (NR) science, announced the initiation of a first-of-its-kind... Read More
